O'Shaughnessy Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

$9.51 Billion
Q2 2024

A detailed history of O'Shaughnessy Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 7,902 shares of REGN stock, worth $8.31 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,902

Previous 6,920 14.19%

Holding current value

$8.31 Million

Previous $6.66 Million 24.7%

% of portfolio

0.09%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $867,302 - $1.05 Million	982 Added 14.19%	7,902 $8.31 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $929,770 - $1.02 Million	1,030 Added 17.49%	6,920 $6.66 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $118,602 - $134,900	153 Added 2.67%	5,890 $5.17 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $1.77 Million - $2.16 Million	2,553 Added 80.18%	5,737 $4.72 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $142,106 - $168,561	-203 Reduced 5.99%	3,184 $2.29 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $17,692 - $21,501	26 Added 0.77%	3,387 $2.78 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $247,061 - $268,236	350 Added 11.62%	3,361 $2.42 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $803,558 - $1.01 Million	1,400 Added 86.9%	3,011 $2.07 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $169,440 - $228,301	309 Added 23.73%	1,611 $952,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $317,198 - $372,263	533 Added 69.31%	1,302 $909,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $26,087 - $32,206	-48 Reduced 5.88%	769 $486,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $146,951 - $174,325	256 Added 45.63%	817 $495,000
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $17,020 - $20,107	36 Added 6.86%	561 $313,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $41,545 - $50,982	-93 Reduced 15.05%	525 $248,000
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $13,870 - $17,631	-29 Reduced 4.48%	618 $299,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $15,797 - $19,088	29 Added 4.69%	647 $362,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $261,459 - $341,277	530 Added 602.27%	618 $385,000
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $3,025 - $4,449	-9 Reduced 9.28%	88 $43,000
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $26,590 - $36,521	97 New	97 $36,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Account

O'Shaughnessy Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History